伟思医疗：股东拟减持不超3%公司股份

Group 1 - The core point of the announcement is that Zhida Venture Capital, a shareholder of Weisi Medical, plans to reduce its stake in the company by selling up to 287.31 million shares, which represents 3% of the total share capital [1] - Zhida Venture Capital currently holds 6.7583 million shares, accounting for 7.06% of the total share capital, and is considered a concerted actor with the actual controller Wang Zhiyu [1] - The reduction plan will take place from February 9, 2026, to May 8, 2026, through centralized bidding and block trading, with a maximum of 95.77 million shares to be sold via centralized bidding and 191.54 million shares via block trading [1] Group 2 - The reason for the share reduction is stated as a need for personal funds, and there is uncertainty regarding the implementation of the reduction plan [1] - It is confirmed that the completion of this share reduction will not result in a change of control of the company [1]